FDA Denies Majority Of Requests To Reclassify Low-Risk De Novo Devices
This article was originally published in The Gray Sheet
Executive Summary
Close to 63% of requests to FDA seeking Class I or Class II status for de novo devices without a predicate have been denied to date, FDA staffers say.